| Genital Diseases, Female |
| Recruiting | 4 | 1300 | Europe | Biomarker (ER/PR) guided lymphadenectomy, Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer | Haukeland University Hospital | Endometrial Cancer | 12/20 | 12/33 | | |
NCT01561586: Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer |
|
|
| Recruiting | 3 | 374 | RoW | Weekly cisplatin with RT, Cisplatin, Tri-weekly cisplatin with RT | Korea Cancer Center Hospital, Seoul National University Hospital, Asan Medical Center, Gangnam Severance Hospital | Cervical Cancer | 03/20 | 03/23 | | |
NACOPRAD, NCT02422563: NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB |
|
|
| Not yet recruiting | 3 | 534 | Europe | hysterectomy, Radiation, Cisplatin, Paclitaxel, Carboplatin, Ifosfamide | Charite University, Berlin, Germany | Cervical Cancer | 10/20 | 10/25 | | |
COMBAT-Cx, NCT03005743: Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial |
|
|
| Recruiting | 3 | 1050 | RoW | Magnetic Resonance Image based Brachytherapy, Conventional Radiograph based Brachytherapy | Tata Memorial Hospital | Cervical Cancer | 12/21 | 12/23 | | |
| Recruiting | 3 | 700 | RoW | NACT (Paclitaxel + Cisplatin or carboplatin), radical surgery | Sun Yat-sen University | PFS, OS, Quality of Life | 12/22 | 12/22 | | |
NCT03071289: A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer |
|
|
| Recruiting | 3 | 540 | RoW | Radiation Method B, Cisplatin, Radiation Method A | Sun Yat-sen University | Cervical Cancer, Lymphocyst, Radiation Therapy | 03/25 | 03/25 | | |
NCT02490748: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer |
|
|
| Active, not recruiting | 3 | 10 | RoW | Radiofrequency ablation, RFA, Cytokine-induced killer cells, CIK | The First People's Hospital of Changzhou | Cervical Cancer | 06/38 | 06/40 | | |
NCT02159820: Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer |
|
|
| Recruiting | 2/3 | 500 | RoW | Decitabine (DTC Arm), Paclitaxel and Carboplatin (TC Arm) | Chinese PLA General Hospital | Primary Malignant Neoplasm of Ovary, FIGO Stages II to IV | 06/24 | 06/24 | | |
NCT02432365: Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy |
|
|
| Recruiting | 2 | 64 | RoW | paclitaxel, Taxol, cisplatin, Kemoplat, Radical hysterectomy and bilateral pelvic lymphadenectomy, RH-PLND | Chang Gung Memorial Hospital, Asian Gynecologic Oncology Group, Taiwanese Gynecologic Oncology Group | Cervical Cancer | 12/23 | 12/23 | | |
NCT02487693: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma |
|
|
| Active, not recruiting | 2 | 50 | RoW | Radiofrequency ablation, RFA, Cytokine-induced killer cells, CIK | The First People's Hospital of Changzhou | Ovarian Carcinoma | 06/38 | 06/40 | | |
| Active, not recruiting | 1/2 | 22 | Europe | intensity modulated radiotherapy, IMRT, Intracavitary brachytherapy, Cisplatin | Queen Mary University of London, Barts & The London NHS Trust, Barts Cancer Institute | Locally Advanced Cervical Cancer | 04/16 | 04/18 | | |
NCT01926821: Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy |
|
|
| Recruiting | 1 | 200 | RoW | Sonifilan, sizofiran inj 20mg, Code : XSISO | Asan Medical Center | Cervical Cancer | 12/25 | 12/25 | | |
NCT01267461: Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells |
|
|
| Available | N/A | | RoW | Tissue sample from tumor | Meir Medical Center, Tel Aviv University | Endometrial Cancer, Colon Cancer | | | | |
ENDORE, NCT01291576: Functional Outcomes of Surgical Management of Deep Endometriosis Infiltrating the Rectum |
|
|
| Active, not recruiting | N/A | 60 | Europe | Rectal/colorectal segmental resection, Anterior rectal resection, Rectal nodule excision, Conservative sergery of the rectum | University Hospital, Rouen | Endometriosis, Rectum | 09/13 | 09/23 | | |
NCT02069652: Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention, |
|
|
| No Longer Available | N/A | | RoW | Lifestyle Counseling | Kaohsiung Medical University Chung-Ho Memorial Hospital | HIV | 12/14 | | | |
NCT02090127: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient |
|
|
| No Longer Available | N/A | | US | ficlatuzumab, AV-299, SCH 900105 | AVEO Pharmaceuticals, Inc. | Mullerian Mixed Tumor of Ovary | | | | |
NCT00975546: HIV-discordant Couple Intrauterine Insemination |
|
|
| No Longer Available | N/A | | US | Sperm washing and testing for HIV contamination, Intrauterine Insemination | University of Missouri-Columbia | Infertility, HIV Infections | | | | |
| Recruiting | N/A | 60 | Europe | | University of Aarhus | Endometriosis | 12/16 | 09/30 | | |
NCT02950350: Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer |
|
|
| Not yet recruiting | N/A | 50 | RoW | | Shanghai First Maternity and Infant Hospital | Cervical Cancer, Stage IIB, Cervical Cancer Stage IIIA, Cervical Cancer Stage IIIB, Cervical Cancer, Stage IVA | 12/16 | 12/23 | | |
LLLT, NCT02764034: Effect of Low Level Laser Therapy on Endometrial Cells: An In Vitro Study |
|
|
| Available | N/A | | RoW | Low level Laser diode machine | Cairo University | Infertility | | | | |
NCT03063710: Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan |
|
|
| No Longer Available | N/A | | Japan | olaparib | AstraZeneca | PSR Ovarian Cancer With a BRCA Mutation | | | | |
NCT02686463: Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy |
|
|
| Not yet recruiting | N/A | 150 | RoW | Laparoscopy, Laparotomy | Shengjing Hospital | Ovarian Cancer | 06/18 | 06/23 | | |
NCT01628757: Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer |
|
|
| Recruiting | N/A | 1400 | RoW | | Ding Ma, Zhejiang University, Shandong University, Sun Yat-sen University, Wuhan University, Hubei Women and Children's Hospital, Wuhan General Hospital of Guangzhou Military Command, Xiangfan Central Hospital, Wuhan Central Hospital, Hubei University for nationalities | Cervical Cancer | 12/18 | 12/23 | | |
NCT03006939: Fluid Balance During Surgery for Ovarian Cancer |
|
|
| Recruiting | N/A | 60 | Europe | Cytoreductive surgery | University Hospital, Bonn | Ovarian Neoplasm, Fluid Therapy | 12/19 | 12/22 | | |
NCT02741102: Uterine Transplant in Absolute Uterine Infertility (AUIF) |
|
|
| Not yet recruiting | N/A | 10 | US | Uterine Transplant | Brigham and Women's Hospital | Female Infertility | 06/22 | 01/23 | | |
| Active, not recruiting | N/A | 240 | RoW | TH, TH/BSO, BPLND | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
| Recruiting | N/A | 200 | RoW | | Kangbuk Samsung Hospital | Inflammatory Pelvic Disease | 09/24 | 09/24 | | |
| Not yet recruiting | N/A | 50 | Europe | Blood sample | Assistance Publique Hopitaux De Marseille | Cervical Cancer | 09/24 | 09/24 | | |
| Enrolling by invitation | N/A | 10000 | Europe | Screening for cervical cancer | Tampere University, FinnMedi Oy, GlaxoSmithKline | Uterine Cervical Cancer | 12/24 | 12/24 | | |
NCT02471443: Laparoscopic Surgery for Severe Recto-vaginal Endometriosis |
|
|
| Recruiting | N/A | 1000 | Europe | Surgery for severe endometriosis | Royal Surrey County Hospital NHS Foundation Trust | Endometriosis Rectovaginal Septum | 01/25 | 01/40 | | |
NCT02914704: Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) |
|
|
| Recruiting | N/A | 500 | Europe | MRI-HIFU | Turku University Hospital | Uterine Fibroids, Adenomyosis | 12/25 | 12/25 | | |
NCT02869568: Institut Paoli Calmettes Ovarian Cancer Database |
|
|
| Recruiting | N/A | 6000 | Europe | Data collection | Institut Paoli-Calmettes | Ovarian Neoplasms | 01/30 | 12/30 | | |
NCT02869490: Institut Paoli Calmettes Cervical Cancer Database |
|
|
| Recruiting | N/A | 6000 | Europe | Data collection | Institut Paoli-Calmettes | Uterine Cervical Neoplasms | 01/30 | 12/30 | | |
| Recruiting | N/A | 3000 | RoW | | Kangbuk Samsung Hospital | Ovarian Neoplasms | 12/40 | 12/40 | | |
NCT01000259: Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer |
|
|
| Recruiting | N/A | 174 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer, Stage IV Ovarian Cancer | 01/00 | | | |
NCT01164735: Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 169 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |
NCT01198171: Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 243 | US | Laboratory Biomarker Analysis, Study of Socioeconomic and Demographic Variables | Gynecologic Oncology Group, National Cancer Institute (NCI) | Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |
NCT01344837: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer |
|
|
| Not yet recruiting | N/A | 360 | US | Diagnostic Laboratory Biomarker Analysis, Immunohistochemistry Staining Method, Cell/Tissue, Immunohistochemistry, IHC, Immunohistochemistry, Medical Chart Review, Chart Review, Microarray Analysis, gene expression profile, Gene Expression Profiling, Microarray Technology, Microarray-Based Analysis, Study of Socioeconomic and Demographic Variables, Western Blotting, Blotting, Western, WESTERN BLOT | Gynecologic Oncology Group, National Cancer Institute (NCI) | Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |
NCT01445275: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 |
|
|
| Not yet recruiting | N/A | 2605 | US | Evaluation of Cancer Risk Factors, cancer risk factors evaluation, Medical Chart Review, Chart Review, Study of Socioeconomic and Demographic Variables | Gynecologic Oncology Group, National Cancer Institute (NCI) | Fallopian Tube Carcinoma, Hereditary Breast and Ovarian Cancer Syndrome, Ovarian Carcinoma, Primary Peritoneal Carcinoma | 01/00 | | | |
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 3600 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |
